Bedtime device restriction plus desmopressin for bedwetting in kids
Official title: Effect of Bedtime Digital-Device Restriction on the Therapeutic Response to Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis: A Randomized Controlled Trial
Run by Al-Azhar University · NCT07776977 · Data updated 2026-11-12
This trial tests whether limiting screen time at night helps desmopressin work better for children with primary monosymptomatic nocturnal enuresis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 14 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | August 20, 2026 |
| Main results expected | May 2027 |
| Study ends | July 2027 |
| Registry record updated | August 24, 2026 |
| Trial ID | NCT07776977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6–14 with primary monosymptomatic nocturnal enuresis, willing to take desmopressin nightly for 8 weeks, and whose guardians can monitor screen time and wet nights.
✕Probably not a fit
Some participants may not respond to desmopressin or derive additional benefit from restricting bedtime screens.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, open-label, randomized trial in Cairo, Egypt, enrolling 6- to 14-year-olds with primary monosymptomatic nocturnal enuresis. Participants are randomly assigned to receive desmopressin for 8 weeks with either bedtime digital-device restriction (at least 60 minutes before bed) or usual screen use, alongside standard clinical follow-up and dose adjustment. The study will measure the proportion with a full response (no more than one wet night in the last two weeks) and secondary outcomes such as weekly wet nights, partial response, sleep quality, adherence, and relapse four weeks after treatment ends. Baseline data will be collected to identify predictors of response. Outcomes will help determine if behavior modification around screen time enhances pharmacologic treatment.
Why it matters
Potential benefit: If successful, children may achieve better nighttime dryness with a simple behavioral change in addition to medication.
How similar studies have gone: Past studies have shown that behavioral factors can influence enuresis outcomes, but this specific combination with bedtime device restriction is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 6-14 years. * Diagnosis of PMNE (≥2 wet nights/week for ≥6 months, no daytime symptoms, no prior sustained dryness \>6 months). * Willingness to take oral desmopressin nightly for 8 weeks. * Parent/guardian able to monitor and report screen time and wet nights. * Written informed consent from parent/guardian and assent from child (if age-appropriate). Exclusion Criteria: * Secondary enuresis or non-monosymptomatic enuresis (daytime incontinence, urgency, frequency). * Known organic causes (e.g., diabetes mellitus, urinary tract anomalies, neurological disorders). * Current use of other enuresis treatments (alarms, anticholinergics, imipramine) within 4 weeks prior to enrollment. * Severe sleep disorders (e.g., obstructive sleep apnea) or psychiatric conditions affecting compliance. * Inability to comply with study procedures or follow-up.
Where it's running
-
Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
Cairo, Egypt Recruiting
Study contacts
- Principal investigator: Abul-fotouh Ahmed — Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
- Study coordinator: Abul-fotouh Ahmed
- Email: abulfotouhahmed@yahoo.com
- Phone: +201001066756
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Individualized pelvic floor rehab added to standard urotherapy and alarm therapy for kids with bedwetting
This trial tests whether adding personalized pelvic floor muscle training to standard alarm therapy helps reduce dry nights in children aged 5–18 with primary monosymptomatic nocturnal enuresis.
-
Transabdominal vs. Transvaginal Ultrasound in high-risk pregnancies during early weeks
This study tests whether transabdominal ultrasound can visualize fetal structures as well as transvaginal ultrasound in high-risk singleton pregnancies between 9 and 13+6 weeks.
-
Ultrasound-Guided PRP Injections for Nerve Regeneration in Traumatic Peripheral Nerve Injury
This study tests whether ultrasound-guided platelet-rich plasma injections can help nerve regeneration in adults with traumatic peripheral nerve injuries.
-
Dual Trigger vs HCG Trigger for Final Maturation in Normal Responders
In normal responders undergoing ICSI cycles, this study tests whether using a dual trigger (GnRH agonist plus hCG) improves outcomes compared with the standard hCG trigger.
-
Criteria-based Rehabilitation After Tibial Fracture Fixation
This trial tests a structured, criteria-driven rehabilitation plan against usual physiotherapy after tibial fracture surgery to see if it improves leg function.
-
Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men
This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.